| Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression ER Asl, M Amini, S Najafi, B Mansoori, A Mokhtarzadeh, A Mohammadi, ... Life sciences 278, 119499, 2021 | 116 | 2021 |
| The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV N Hemmat, Z Asadzadeh, NK Ahangar, H Alemohammad, B Najafzadeh, ... Archives of Virology 166, 675-696, 2021 | 82 | 2021 |
| Cytotoxic T-lymphocyte antigen-4 in colorectal cancer: another therapeutic side of capecitabine A Derakhshani, S Hashemzadeh, Z Asadzadeh, MA Shadbad, ... Cancers 13 (10), 2414, 2021 | 68 | 2021 |
| miR‐330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer B Mansoori, A Mohammadi, S Naghizadeh, M Gjerstorff, D Shanehbandi, ... Journal of cellular physiology 235 (2), 920-931, 2020 | 60 | 2020 |
| The oncogenic potential of NANOG: An important cancer induction mediator B Najafzadeh, Z Asadzadeh, R Motafakker Azad, A Mokhtarzadeh, ... Journal of cellular physiology 236 (4), 2443-2458, 2021 | 52 | 2021 |
| Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness B Mansoori, PHG Duijf, A Mohammadi, S Najafi, E Roshani, ... Expert Opinion on Therapeutic Targets 24 (3), 255-265, 2020 | 49 | 2020 |
| Nanog, as a key cancer stem cell marker in tumor progression P Vasefifar, R Motafakkerazad, LA Maleki, S Najafi, F Ghrobaninezhad, ... Gene 827, 146448, 2022 | 46 | 2022 |
| The latest findings of PD-1/PD-L1 inhibitor application in gynecologic cancers O Kooshkaki, A Derakhshani, H Safarpour, S Najafi, P Vahedi, O Brunetti, ... International journal of molecular sciences 21 (14), 5034, 2020 | 39 | 2020 |
| Weighted gene co-expression network analysis combined with machine learning validation to identify key modules and hub genes associated with SARS-CoV-2 infection H Karami, A Derakhshani, M Ghasemigol, M Fereidouni, ... Journal of clinical medicine 10 (16), 3567, 2021 | 35 | 2021 |
| miR-330 regulates colorectal cancer oncogenesis by targeting BACH1 S Shirjang, B Mansoori, A Mohammadi, N Shajari, PHG Duijf, S Najafi, ... Advanced pharmaceutical bulletin 10 (3), 444, 2020 | 27 | 2020 |
| The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy Z Asadzadeh, B Mansoori, A Mohammadi, T Kazemi, A Mokhtarzadeh, ... Biomedicine & Pharmacotherapy 137, 111364, 2021 | 25 | 2021 |
| Restoration of miR‐330 expression suppresses lung cancer cell viability, proliferation, and migration A Mohammadi, B Mansoori, PHG Duijf, E Safarzadeh, L Tebbi, S Najafi, ... Journal of cellular physiology 236 (1), 273-283, 2021 | 19 | 2021 |
| Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction H Alemohammad, Z Asadzadeh, N Hemmat, B Najafzadeh, P Vasefifar, ... Life Sciences 260, 118337, 2020 | 16 | 2020 |
| Coronavirus disease 2019: a brief review of the clinical manifestations and pathogenesis to the novel management approaches and treatments O Kooshkaki, A Derakhshani, AM Conradie, N Hemmat, SG Barreto, ... Frontiers in Oncology 10, 572329, 2020 | 16 | 2020 |
| Interaction between DNA damage response and autophagy in colorectal cancer E Roshani-Asl, B Mansori, A Mohammadi, S Najafi, F Danesh-Pouya, ... Gene 730, 144323, 2020 | 16 | 2020 |
| NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer ZA Serej, A Ebrahimi, T Kazemi, S Najafi, M Amini, P Nastarin, ... Gene 801, 145844, 2021 | 10 | 2021 |
| The synergy between miR-486–5p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells B Mansoori, S Najafi, A Mohammadi, H AsadollahSeraj, P Savadi, ... Biomedicine & Pharmacotherapy 141, 111925, 2021 | 8 | 2021 |
| The potential of B7-H6 as a therapeutic target in cancer immunotherapy A Mohammadi, S Najafi, M Amini, B Mansoori, A Baghbanzadeh, ... Life Sciences 304, 120709, 2022 | 7 | 2022 |
| The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target P Sameti, M Tohidast, M Amini, SZ Bahojb Mahdavi, S Najafi, ... Cancer Cell International 23 (1), 134, 2023 | 6 | 2023 |
| The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment H Hassanian, Z Asadzadeh, A Baghbanzadeh, A Derakhshani, A Dufour, ... Frontiers in Immunology 13, 938063, 2022 | 6 | 2022 |
behzad baradaranImmunology Research Center, Tabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
